CSCI Research Brief

Topical Cannabinoid Treatment of Thumb Basal Joint Arthritis

Heineman JT, Forster GL, Stephens KL, Cottler PS, Timko MP, DeGeorge BR. A randomized controlled trial of topical cannabidiol for the treatment of thumb basal joint arthritis. The Journal of Hand Surgery. 2022;47(7):611-620. doi:10.1016/j.jhsa.2022.03.002

This randomized placebo study aimed to evaluate the effect of topical cannabidiol (CBD) application in the treatment of basal joint arthritis symptoms.


Basal joint arthritis affects a part of the thumb next to the wrist; it is a prevalent type of arthritis. Wear of cartilage at the ends of bones that form your thumb’s joint causes the condition. Symptoms include pain, particularly with pinching or grabbing movements.

Study Findings  

The phase two, randomized placebo study involved the treatment of either a placebo or topical (i.e., on the skin) CBD to participants with thumb basal joint arthritis. A 6.2 mg/ml dose of topical CBD treatment was administered twice daily for two weeks.

There was a significant improvement in pain measurements among participants who received CBD. No adverse effects were observed. Scientists noted an improvement in hand range of motion or grasp strength among those who received CBD.


Researchers found that topical CBD treatment significantly reduced pain and disability in thumb basal joint arthritis without adverse effects.

Link to study:

General Disclaimer

Center for Scientific Cannabinoid Information (CSCI) has placed information, including links to other websites or content belonging to or originating from third parties, on this website as a service to the general public and for general informational and educational purposes only.  The information on this website is not intended to substitute particularized advice of specialists or qualified professionals.  No content on this website should ever be used as a substitute for direct advice from appropriate professionals or qualified specialists.  This website could include inaccuracies or typographical errors.  The materials on this website do not constitute medical advice, do not necessarily reflect the opinions of CSCI or any of its employees, agents, affiliates, or subsidiaries, and are not guaranteed to be correct, complete, or up‐to‐date.  The publications, articles, and information on this website are provided as is without warranty of any kind, either express or implied, regarding accuracy, adequacy, validity, reliability, availability, or completeness, and CSCI does not warrant, endorse, guarantee, or assume responsibility for the accuracy or reliability of any information included on this website from third-party websites linked through this website.  UNDER NO CIRCUMSTANCE SHALL CSCI HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE OR RELIANCE ON ANY SUCH INFORMATION PROVIDED ON THIS WEBSITE. YOUR USE OF THIS WEBSITE AND YOUR RELIANCE ON ANY INFORMATION ON THIS WEBSITE IS SOLELY AT YOUR OWN RISK.

You cannot copy content of this page